ESTIMATING THE BUDGET IMPACT OF ADDING OMALIZUMAB TO STANDARD THERAPY IN PATIENTS WITH UNCONTROLLED SEVERE ALLERGIC ASTHMA FROM PRIVATE HEALTH CARE SYSTEM PERSPECTIVE IN BRAZIL

VALUE IN HEALTH

卷 16, 期 3, 页码 A232-A233

ELSEVIER SCIENCE INC

-

Economics Health Care Sciences & Services Health Policy & Services